Skip to main content

Table 5 Physical and hormonal characteristics among women categorised based on the annual rates of change in BMD

From: Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study

 

Mild bone density loss

(n = 47)

Moderate bone density loss

(n = 47)

Severe bone density loss

(n = 47)

Age (years)

44.68 ± 2.45

45.09 ± 2.53

45.34 ± 2.88

Weight (kg)

54.33 ± 9.47

56.60 ± 9.46

55.75 ± 9.90

Height (cm)

158.29 ± 5.78

159.69 ± 5.65

159.38 ± 5.91

Body mass index

21.66 ± 3.48

22.10 ± 3.26

21.91 ± 3.38

Systolic blood pressure (mmHg)

121.72 ± 10.69

119.91 ± 11.63

124.50 ± 11.77

Diastolic blood pressure (mmHg)

79.30 ± 9.82

77.36 ± 9.88

79.39 ± 8.26

FSH (mIU/mL)

37.34 ± 50.03

21.60 ± 22.63

39.73 ± 45.66

E2 (pg/mL)

97.77 ± 116.95

109.96 ± 116.26

66.24 ± 87.95

TSH (μIU/mL)

1.42 ± 0.65

1.79 ± 1.28

2.16 ± 1.34

Abnormally high TSH levels (n, %)

0 (0)

2 (4.3)

4 (8.5)

Free T4 (μg/dL)

1.08 ± 0.17

1.07 ± 0.15

1.08 ± 0.17

AMH (ng/mL)

0.32 ± 0.54

0.31 ± 0.40

0.43 ± 0.81

TRACP-5b (mU/dL)

251.95 ± 108.39

248.40 ± 119.49

236.21 ± 126.64

BMD (g/cm2)

1.11 ± 0.19

1.17 ± 0.14

1.15 ± 0.13

BMD change (g/cm2)

0.02 ± 0.02

0.01 ± 0.00

0.03 ± 0.02

BMD rate of change (%/year)

2.07 ± 2.24

-0.64 ± 0.50

-3.03 ± 1.12

Postmenopausal (n, %)

23 (48.94)

15 (31.91)

15 (31.91)

Age at menopause (years)

48.04 ± 2.10

46.8 ± 4.07

45.13 ± 3.76

  1. Data are presented as means ± SD or number of cases (%)
  2. Abnormally high TSH levels: ≥ 4.23 μIU/mL
  3. AMH, anti-Müllerian hormone; BMD, bone mineral density; E2, oestradiol; FSH, follicle-stimulating hormone; T4, thyroxine; TSH, thyroid-stimulating hormone; TRACP-5b, tartrate-resistant acid phosphatase-5b